Page 118 - Canine Lameness
P. 118

90  6  The Myofascial Examination

            with a comorbid issue(s). In primary MPS, the localization of pain and dysfunction causing lame-
            ness will not be properly identified without a myofascial examination. As such, the diagnosis may
            be missed and appropriate treatment may not be initiated. Secondary MPS is highly prevalent in
            both people and dogs affected by any orthopedic condition or recovering from orthopedic and/or
            neurologic surgeries as described above.
              Many treatment options for MPS have been described (Gerwin 2016). For example, treatment
            with dry needling has been shown to benefit patients with secondary MPS (Janssens 1991; Espejo‐
            Antunez et al. 2017). It has also been successfully used to improve comfort after total knee arthro-
            plasty  in  people  (Mayoral  et  al.  2013).  While  there  is  still  some  controversy  about  the  use  in
            veterinary medicine, a better understanding of the patterns of myalgia and dysfunction associated
            secondary MPS may assist in localization of the primary issue as well as identification of additional
            areas for therapeutic intervention.
              It is important to understand that common imaging modalities (radiography as well as standard
            ultrasound) are unable to diagnose MTPs. This in turn may place fault with a lesion that is not the
            real etiology (but can be identified with these diagnostic means).


              References


            Alvarez, D.J. and Rockwell, P.G. (2002). Trigger points diagnosis and management. American Family
              Physician 65 (4): 653–660.
            Chen, Q., Wang, H.‐J., Gay, R.E. et al. (2016). Quantification of myofascial taut bands. Archives of
              Physical Medicine and Rehabilitation 97 (1): 67–73.
            Dommerholt, J. and Gerwin, R.D. (2015). A critical evaluation of Quintner et al.: missing the point.
              Journal of Bodywork and Movement Therapies 19 (2): 193–204.
            Espejo‐Antunez, L., Tejeda, J.F., Albornoz‐Cabello, M. et al. (2017). Dry needling in the management
              of myofascial trigger points: a systematic review of randomized controlled trials. Complementary
              Therapies in Medicine 33: 46–57.
            Frank, E.M. (1999). Myofascial trigger point diagnostic criteria in the dog. Journal of Musculoskeletal
              Pain 7 (1–2): 231–237.
            Gerwin, R.D. (2010). Myofascial pain syndrome. In: Muscle Pain: Diagnosis and Treatment (eds.
              S. Mense and R.D. Gerwin), 15–83. Berlin: Springer.
            Gerwin, R.D. (2016). Myofascial trigger point pain syndromes. Seminars in Neurology 36 (5): 469–473.
            Janssens, L.A. (1991). Trigger points in 48 dogs with myofascial pain syndromes. Veterinary Surgery 20
              (4): 274–278.
            Janssens, L.A. (1992). Trigger point therapy. Problems in Veterinary Medicine 4 (1): 117–124.
            Lavelle, E.D., Lavelle, W., and Smith, H.S. (2007). Myofascial trigger points. Anesthesiology Clinics 25
              (4): 841–851. vii–viii.
            Mayoral, O., Salvat, I., Martin, M.T. et al. (2013). Efficacy of myofascial trigger point dry needling in
              the prevention of pain after total knee arthroplasty: a randomized, double‐blinded, placebo‐
              controlled trial. Evidence‐based Complementary and Alternative Medicine 2013: 694941.
            Quintner, J.L., Bove, G.M., and Cohen, M.L. (2015). A critical evaluation of the trigger point
              phenomenon. Rheumatology (Oxford) 54 (3): 392–399.
            Shah, J.P. and Gilliams, E.A. (2008). Uncovering the biochemical milieu of myofascial trigger points
              using in vivo microdialysis: an application of muscle pain concepts to myofascial pain syndrome.
              Journal of Bodywork and Movement Therapies 12 (4): 371–384.
   113   114   115   116   117   118   119   120   121   122   123